請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40646
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 鄧哲明教授(Che-Ming Teng) | |
dc.contributor.author | Tzu-Hsuan Chen | en |
dc.contributor.author | 陳姿璇 | zh_TW |
dc.date.accessioned | 2021-06-14T16:54:28Z | - |
dc.date.available | 2009-09-11 | |
dc.date.copyright | 2008-09-11 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-07-29 | |
dc.identifier.citation | Abe Y, Masuda H (2000) Genetic alterations of sporadic colorectal cancer with microsatellite instability, especially characteristics of primary multiple colorectal cancers. J Surg Oncol 74: 249-256
Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337 Brozovic A, Fritz G, Christmann M, Zisowsky J, Jaehde U, Osmak M, Kaina B (2004) Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. International Journal of Cancer 112: 974-985 Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343-2351 Aris SM, Gewirtz DA, Ryan JJ, Knott KM, Farrell NP (2007) Promotion of DNA strand breaks, interstrand cross-links and apoptotic cell death in A2780 human ovarian cancer cells by transplatinum planar amine complexes. Biochem Pharmacol 73: 1749-1757 Basu A, Haldar S (1998) Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein. Int J Oncol 13: 659-664 Bedenne L, Faivre J, Boutron MC, Piard F, Cauvin JM, Hillon P (1992) Adenoma--carcinoma sequence or 'de novo' carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer 69: 883-888 Behrens A, Sibilia M, Wagner EF (1999) Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 21: 326-329 Berglund CM, Radesater AC, Persson MA, Budd Haeberlein SL (2004) UV-induced apoptosis in SH-SY5Y cells: contribution to apoptosis by JNK signaling and cytochrome c. J Neurosci Res 78: 580-589 Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM (2003) Discovery of JSI-124 (Cucurbitacin I), a Selective Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathway Inhibitor with Potent Antitumor Activity against Human and Murine Cancer Cells in Mice. Cancer Res 63: 1270-1279 Boccarelli A, Giordano D, Natile G, Coluccia M (2006) Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells. Biochem Pharmacol 72: 280-292 Bost F, McKay R, Bost M, Potapova O, Dean NM, Mercola D (1999) The Jun Kinase 2 isoform Is Preferentially Required for Epidermal Growth Factor-Induced Transformation of Human A549 Lung Carcinoma Cells. Mol Cell Biol 19: 1938-1949 Cande C, Cecconi F, Dessen P, Kroemer G (2002a) Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci 115: 4727-4734 Cande C, Cohen I, Daugas E, Ravagnan L, Larochette N, Zamzami N, Kroemer G (2002b) Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 84: 215-222 Chen CC, Wu LG, Ko FN, Teng CM (1994) Antiplatelet aggregation principles of Dendrobium loddigesii. J Nat Prod 57: 1271-1274 Chen HY, Shiao MS, Huang YL, Shen CC, Lin YL, Kuo YH, Chen CC (1999) Antioxidant principles from Ephemerantha lonchophylla. J Nat Prod 62: 1225-1227 Chen JC, Chiu MH, Nie RL, Cordell GA, Qiu SX (2005a) Cucurbitacins and cucurbitane glycosides: structures and biological activities. Nat Prod Rep 22: 386-399 Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM, Huang DC (2005b) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393-403 Chen YC, Lu PH, Pan SL, Teng CM, Kuo SC, Lin TP, Ho YF, Huang YC, Guh JH (2007) Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways. Biochem Pharmacol 74: 10-19 Chen YR, Meyer CF, Tan TH (1996) Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J Biol Chem 271: 631-634 Chiang JM, Chou YH, Chou TB (1998) K-ras codon 12 mutation determines the polypoid growth of colorectral cancer. Cancer Res 58: 3289-3293 Cho SG, Choi EJ (2002) Apoptotic signaling pathways: caspases and stress-activated protein kinases. J Biochem Mol Biol 35: 24-27 Concannon CG, Koehler BF, Reimertz C, Murphy BM, Bonner C, Thurow N, Ward MW, Villunger A, Strasser A, Kogel D, Prehn JH (2007) Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway. Oncogene 26: 1681-1692 Corvinus FM, Orth C, Moriggl R, Tsareva SA, Wagner S, Pfitzner EB, Baus D, Kaufmann R, Huber LA, Zatloukal K, Beug H, Ohlschlager P, Schutz A, Halbhuber KJ, Friedrich K (2005) Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 7: 545-555 Cregan SP, Dawson VL, Slack RS (2004) Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 23: 2785-2796 Davis RJ (2000) Signal Transduction by the JNK Group of MAP Kinases. Cell 103: 239-252 de Carcer G, de Castro IP, Malumbres M (2007) Targeting cell cycle kinases for cancer therapy. Curr Med Chem 14: 969-985 de Gramont A, Bosset JF, Milan C, Rougier P, Bouche O, Etienne PL, Morvan F, Louvet C, Guillot T, Francois E, Bedenne L (1997) Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol 15: 808-815 Diaz GD, Li Q, Dashwood RH (2003) Caspase-8 and apoptosis-inducing factor mediate a cytochrome c-independent pathway of apoptosis in human colon cancer cells induced by the dietary phytochemical chlorophyllin. Cancer Res 63: 1254-1261 Donovan M, Cotter TG (2004) Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim Biophys Acta 1644: 133-147 Efeyan A, Serrano M (2007) p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 6: 1006-1010 Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516 Erhart LM, Lankat-Buttgereit B, Schmidt H, Wenzel U, Daniel H, Goke R (2005) Flavone initiates a hierarchical activation of the caspase-cascade in colon cancer cells. Apoptosis 10: 611-617 Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348 Fadeel B, Zhivotovsky B, Orrenius S (1999) All along the watchtower: on the regulation of apoptosis regulators. FASEB J 13: 1647-1657 Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN (1998) 'Loop' domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Cancer Res 58: 3202-3208 Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767 Fuller RW, Cardellina JH, 2nd, Cragg GM, Boyd MR (1994) Cucurbitacins: differential cytotoxicity, dereplication and first isolation from Gonystylus keithii. J Nat Prod 57: 1442-1445 Garcia-Carbonero R, Supko JG (2002) Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin Cancer Res 8: 641-661 Gardner MK, Hunt AJ, Goodson HV, Odde DJ (2008) Microtubule assembly dynamics: new insights at the nanoscale. Current Opinion in Cell Biology 20: 64-70 Garner AP, Weston CR, Todd DE, Balmanno K, Cook SJ (2002) Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint. Oncogene 21: 8089-8104 Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, Sardet C, Weinberg RA (1996) Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12: 1173-1180 Godefroy N, Lemaire C, Renaud F, Rincheval V, Perez S, Parvu-Ferecatu I, Mignotte B, Vayssiere JL (2004) p53 can promote mitochondria- and caspase-independent apoptosis. Cell Death Differ 11: 785-787 Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DK, Wright M, Chernoff J, Clark EA, Krebs EG (1998) Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J 17: 2224-2234 Green DR (2005) Apoptotic pathways: ten minutes to dead. Cell 121: 671-674 Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281: 1309-1312 Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600 Grothey A, Sargent D, Goldberg RM, Schmoll HJ (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22: 1209-1214 Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J (1997) Molecular biology of colorectal cancer. Curr Probl Cancer 21: 233-300 Hadfield JA, Ducki S, Hirst N, McGown AT (2003) Tubulin and microtubules as targets for anticancer drugs. Prog Cell Cycle Res 5: 309-325 Haldar S, Basu A, Croce CM (1997) Bcl2 Is the Guardian of Microtubule Integrity. Cancer Res 57: 229-233 Haldar S, Chintapalli J, Croce CM (1996) Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253-1255 Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M, Rubin LL (1995) A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14: 927-939 Harbour JW, Dean DC (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 14: 2393-2409 Haritunians T, Gueller S, Zhang L, Badr R, Yin D, Xing H, Fung MC, Koeffler HP (2008) Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells. Leuk Res 32: 1366-1373 Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816 Hibi M, Lin A, Smeal T, Minden A, Karin M (1993) Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7: 2135-2148 Ho CK, Chen CC (2003) Moscatilin from the orchid Dendrobrium loddigesii is a potential anticancer agent. Cancer Invest 21: 729-736 Hochedlinger K, Wagner EF, Sabapathy K (2002) Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis. Oncogene 21: 2441-2445 Huang X, Traganos F, Darzynkiewicz Z (2003) DNA damage induced by DNA topoisomerase I- and topoisomerase II-inhibitors detected by histone H2AX phosphorylation in relation to the cell cycle phase and apoptosis. Cell Cycle 2: 614-619 Huang YC, Guh JH, Teng CM (2005) Denbinobin-mediated anticancer effect in human K562 leukemia cells: role in tubulin polymerization and Bcr-Abl activity. J Biomed Sci 12: 113-121 Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342 Ichijo H, Nishida E, Irie K, ten DP, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94 Ip YT, Davis RJ (1998) Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. Curr Opin Cell Biol 10: 205-219 Jaattela M, Tschopp J (2003) Caspase-independent cell death in T lymphocytes. Nat Immunol 4: 416-423 Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J, MacLean KH, Han J, Chittenden T, Ihle JN, McKinnon PJ, Cleveland JL, Zambetti GP (2003) Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4: 321-328 Jiang J, Matranga CB, Cai D, Latham VM, Jr., Zhang X, Lowell AM, Martelli F, Shapiro GI (2003) Flavopiridol-Induced Apoptosis during S Phase Requires E2F-1 and Inhibition of Cyclin A-Dependent Kinase Activity. Cancer Res 63: 7410-7422 Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ, Tebbutt NC, van Hazel G, Wierzbicki R, Langer C, Moore MJ (2007) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357: 2040-2048 Jordan A, Hadfield JA, Lawrence NJ, McGown AT (1998) Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev 18: 259-296 Jordan MA (2002) Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr Med Chem Anticancer Agents 2: 1-17 Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4: 253-265 Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432: 316-323 Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257 Kislitsin D, Lerner A, Rennert G, Lev Z (2002) K-ras mutations in sporadic colorectal tumors in Israel: unusual high frequency of codon 13 mutations and evidence for nonhomogeneous representation of mutation subtypes. Dig Dis Sci 47: 1073-1079 Kroemer G, Martin SJ (2005) Caspase-independent cell death. Nat Med 11: 725-730 Lane DP (1992) p53, guardian of the genome. Nature 358: 15-16 Lavin MF, Birrell G, Chen P, Kozlov S, Scott S, Gueven N (2005) ATM signaling and genomic stability in response to DNA damage. Mut Res 569: 123-132 Lee ER, Kang YJ, Kim HJ, Choi HY, Kang GH, Kim JH, Kim BW, Jeong HS, Park YS, Cho SG (2008) Regulation of apoptosis by modified naringenin derivatives in human colorectal carcinoma RKO cells. J Cell Biochem 104:259-273 Lee YH, Park JD, Baek NI, Kim SI, Ahn BZ (1995) In vitro and in vivo antitumoral phenanthrenes from the aerial parts of Dendrobium nobile. Planta Med 61: 178-180 Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB, Bar-Sagi D, Davis RJ (2002) The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol 22: 4929-4942 Letai AG (2008) Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer 8: 121-132 Li H, Zhu H, Xu CJ, Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501 Li LY, Luo X, Wang X (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412: 95-99 Liao JC (1993) Flora of Taiwan. Vol. 1, 2nd edn. Taipei: Editorial Committee of the Flora of Taiwan Lin A (2003) Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 25: 17-24 Lin Q, Lai R, Chirieac LR, Li C, Thomazy VA, Grammatikakis I, Rassidakis GZ, Zhang W, Fujio Y, Kunisada K, Hamilton SR, Amin HM (2005) Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: Inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am J Pathol 167: 969-980 Lin SC, Chueh SC, Hsiao CJ, Li TK, Chen TH, Liao CH, Lyu PC, Guh JH (2007) Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle. Neoplasia 9: 830-839 Ling Y-H, Tornos C, Perez-Soler R (1998) Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis. J Biol Chem 273: 18984-18991 Liu J, Lin A (2005) Role of JNK activation in apoptosis: a double-edged sword. Cell Res 15: 36-42 Liu T, Zhang M, Zhang H, Sun C, Deng Y (2008) Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 347: 118-127 Liu X, Bian C, Ren K, Jin H, Li B, Shao RG (2007) Lidamycin induces marked G2 cell cycle arrest in human colon carcinoma HT-29 cells through activation of p38 MAPK pathway. Oncol Rep 17: 597-603 Liu X, Zou H, Slaughter C, Wang X (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175-184 Lockshin RA, Zakeri Z (2002) Caspase-independent cell deaths. Curr Opin Cell Biol 14: 727-733 Lu PH, Kung FL, Kuo SC, Chueh SC, Guh JH (2006) Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery. Naunyn Schmiedebergs Arch Pharmacol 374: 223-33 Lu Y, Shihua W, Qiuhui Z, Feiyan L, Ping W (2007) 23,24-Dihydrocucurbitacin B induces G2/M cell-cycle arrest and mitochondria-dependent apoptosis in human breast cancer cells (Bcap37). Cancer Lett 256: 267-278 Ma XT, Wang S, Ye YJ, Du RY, Cui ZR, Somsouk M (2004) Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. World J Gastroenterol 10: 1569-1573 MacFarlane M, Cohen GM, Dickens M (2000) JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation. Biochem J 348: 93-101 Manfredi JJ, Parness J, Horwitz SB (1982) Taxol binds to cellular microtubules. J Cell Biol 94: 688-696 Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, Chabert C, Gillieron C, Boschert U, Vial-Knecht E, Martinou J-C, Arkinstall S (1997) Bcl-2 Undergoes Phosphorylation by c-Jun N-terminal Kinase/Stress-activated Protein Kinases in the Presence of the Constitutively Active GTP-binding Protein Rac1. J Biol Chem 272: 25238-25242 McClue SJ, Blake D, Clarke R, Cowan A, Cummings L, Fischer PM, MacKenzie M, Melville J, Stewart K, Wang S, Zhelev N, Zheleva D, Lane DP (2002) In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine). Int J Cancer 102: 463-468 Messersmith WA, Hidalgo M (2007) Panitumumab, a monoclonal anti epidermal growth factor receptor antibody in colorectal cancer: another one or the one? Clin Cancer Res 13: 4664-4666 Metzinger DS, Taylor DD, Gercel-Taylor C (2006) Induction of p53 and drug resistance following treatment with cisplatin or paclitaxel in ovarian cancer cell lines. Cancer Lett 236: 302-308 Millan A, Huerta S (2007) Apoptosis-Inducing Factor and Colon Cancer. J Surg Res In Press, Corrected Proof Mimori-Kiyosue Y, Tsukita S (2001) Where is APC going? J Cell Biol 154: 1105-1109 Misra RN, Xiao HY, Kim KS, Lu S, Han WC, Barbosa SA, Hunt JT, Rawlins DB, Shan W, Ahmed SZ, Qian L, Chen BC, Zhao R, Bednarz MS, Kellar KA, Mulheron JG, Batorsky R, Roongta U, Kamath A, Marathe P, Ranadive SA, Sack JS, Tokarski JS, Pavletich NP, Lee FY, Webster KR, Kimball SD (2004) N-(cycloalkylamino)acyl- 2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl) -2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent. J Med Chem 47: 1719-1728 Miyazawa M, Shimamura H, Nakamura S, Sugiura W, Kosaka H, Kameoka H (1999) Moscatilin from Dendrobium nobile, a naturally occurring bibenzyl compound with potential antimutagenic activity. J Agric Food Chem 47: 2163-2167 Mohamad N, Gutierrez A, Nunez M, Cocca C, Martin G, Cricco G, Medina V, Rivera E, Bergoc R (2005) Mitochondrial apoptotic pathways. Biocell 29: 149-161 Montecucco A, Biamonti G (2007) Cellular response to etoposide treatment. Cancer Lett 252: 9-18 Nagata S (2000) Apoptotic DNA fragmentation. Exp Cell Res 256: 12-18 Newmeyer DD, Ferguson-Miller S (2003) Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112: 481-490 Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N (2000) Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis. Science 288: 1053-1058 Ozaki I, Tani E, Ikemoto H, Kitagawa H, Fujikawa H (1999) Activation of stress-activated protein kinase/c-Jun NH2-terminal kinase and p38 kinase in calphostin C-induced apoptosis requires caspase-3-like proteases but is dispensable for cell death. J Biol Chem 274: 5310-5317 Paulovich AG, Toczyski DP, Hartwell LH (1997) When checkpoints fail. Cell 88: 315-321 Pellegrini F, Budman DR (2005) Review: tubulin function, action of antitubulin drugs, and new drug development. Cancer Invest 23: 264-273 Philchenkov A (2004) Caspases: potential targets for regulating cell death. J Cell Mol Med 8: 432-444 Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22 Potapova O, Gorospe M, Bost F, Dean NM, Gaarde WA, Mercola D, Holbrook NJ (2000) c-Jun N-terminal Kinase Is Essential for Growth of Human T98G Glioblastoma Cells. J Biol Chem 275: 24767-24775 Rai SS, Wolff J (1996) Localization of the vinblastine-binding site on beta-tubulin. J Biol Chem 271: 14707-14711 Rashmi R, Kumar S, Karunagaran D (2005) Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL. Carcinogenesis 26: 713-723 Ravagnan L, Roumier T, Kroemer G (2002) Mitochondria, the killer organelles and their weapons. J Cell Physiol 192: 131-137 Reed JC, Kroemer G (2000) Mechanisms of mitochondrial membrane permeabilization. Cell Death Differ 7: 1145 Roos WP, Kaina B (2006) DNA damage-induced cell death by apoptosis. Trends Mol Med 12: 440-450 Rowinsky EK (1997) The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48: 353-374 Rudolf E, Rudolf K, Cervinka M (2008) Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells. Cell Biol Toxicol 24: 123-141 Rugo H, Shtivelman E, Perez A, Vogel C, Franco S, Tan Chiu E, Melisko M, Tagliaferri M, Cohen I, Shoemaker M, Tran Z, Tripathy D (2007) Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res Treat 105: 17-28 Sanchez-Perez I, Murguia JR, Perona R (1998) Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 16: 533-540 Shapiro GI (2006) Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment. J Clin Oncol 24: 1770-1783 Shapiro GI, Edwards CD, Rollins BJ (2000) The physiology of p16(INK4A)-mediated G1 proliferative arrest. Cell Biochem Biophys 33: 189-197 Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512 Shiah HS, Lee WS, Juang SH, Hong PC, Lung CC, Chang CJ, Chou KM, Chang JY (2007) Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036. Biochem Pharmacol 73: 610-619 Shiff SJ, Rigas B (1999) The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J Exp Med 190: 445-450 Shimoda T, Ikegami M, Fujisaki J, Matsui T, Aizawa S, Ishikawa E (1989) Early colorectal carcinoma with special reference to its development de novo. Cancer 64: 1138-1146 Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV, Gallinger S (1994) Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 54: 5527-5530 Spano JP, Milano G, Rixe C, Fagard R (2006) JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications. Eur J Cancer 42: 2668-2670 Srivastava RK, Mi QS, Hardwick JM, Longo DL (1999) Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc Natl Acad Sci U S A 96: 3775-3780 Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL (1998) Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 18: 3509-3517 Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, Rotter V (2006) Regulation of AIF expression by p53. Cell Death Differ 13: 2140-2149 Stewart ZA, Pietenpol JA (2001) p53 Signaling and cell cycle checkpoints. Chem Res Toxicol 14: 243-263 Stewart ZA, Westfall MD, Pietenpol JA (2003) Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol Sci 24: 139-145 Strauss G, Westhoff MA, Fischer-Posovszky P, Fulda S, Schanbacher M, Eckhoff SM, Stahnke K, Vahsen N, Kroemer G, Debatin KM (2007) 4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG. Cell Death Differ 15: 332-343 Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D, Sebti SM (2005) Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24: 3236-3245 Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446 Susin SA, Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, Fassy F, Reed JC, Kroemer G (1997) The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1. J Exp Med 186: 25-37 Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8: 613-621 Tan TT, Degenhardt K, Nelson DA, Beaudoin B, Nieves-Neira W, Bouillet P, Villunger A, Adams JM, White E (2005) Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell 7: 227-238 Tannin-Spitz T, Grossman S, Dovrat S, Gottlieb HE, Bergman M (2007) Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells. Biochem Pharmacol 73: 56-67 Tarapore P, Horn HF, Tokuyama Y, Fukasawa K (2001) Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway. Oncogene 20: 3173-3184 Taverna P, Rendahl K, Jekic-McMullen D, Shao Y, Aardalen K, Salangsang F, Doyle L, Moler E, Hibner B (2007) Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts. Biochem Pharmacol 73: 44-55 Taylor RC, Cullen SP, Martin SJ (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9: 231-241 Thomson BJ (2001) Viruses and apoptosis. Int J Exp Pathol 82: 65-76 Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1316 Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870-874 Uppuluri S, Knipling L, Sackett DL, Wolff J (1993) Localization of the colchicine-binding site of tubulin. Proc Natl Acad Sci U S A 90: 11598-11602 van Loo G, Schotte P, van Gurp M, Demol H, Hoorelbeke B, Gevaert K, Rodriguez I, Ruiz-Carrillo A, Vandekerckhove J, Declercq W, Beyaert R, Vandenabeele P (2001) Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ 8: 1136-1142 Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, Moritz RL, Simpson RJ, Vaux DL (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277: 445-454 Wang LG, Liu XM, Kreis W, Budman DR (1999) The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 44: 355-361 Wang M, Zhang L, Han X, Yang J, Qian J, Hong S, Samaniego F, Romaguera J, Yi Q (2007) Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways. Blood 109: 5455-5462 Wang X, Yang C, Chai J, Shi Y, Xue D (2002) Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science 298: 1587-1592 Wang ZB, Liu YQ, Cui YF (2005) Pathways to caspase activation. Cell Biol Int 29: 489-496 Williams AC, Browne SJ, Yeudal WA, Paterson IC, Marshall CJ, Lane DP, Paraskeva C (1993) Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Oncogene 8: 3063-3072 Willis SN, Adams JM (2005) Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17: 617-625 Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM, Huang DC (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19: 1294-1305 Wils P, Phung-Ba V, Warnery A, Lechardeur D, Raeissi S, Hidalgo IJ, Scherman D (1994) Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. Biochem Pharmacol 48: 1528-1530 Wolpin BM, Mayer RJ (2008) Systemic Treatment of Colorectal Cancer. Gastroenterology 134: 1296-1310 Wu PL, Lin FW, Wu TS, Kuoh CS, Lee KH, Lee SJ (2004) Cytotoxic and anti-HIV principles from the rhizomes of Begonia nantoensis. Chem Pharm Bull (Tokyo) 52: 345-349 Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556 Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang QC, Zhang YJ, Lu R, Chen YX, Fang JY (2008) Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 10: 287-297 Yamamoto K, Ichijo H, Korsmeyer SJ (1999) BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19: 8469-8478 Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P, Flavell RA (1997) Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389: 865-870 Yang KC, Uen YH, Suk FM, Liang YC, Wang YJ, Ho YS, Li IH, Lin SY (2005) Molecular mechanisms of denbinobin-induced anti-tumorigenesis effect in colon cancer cells. World J Gastroenterol 11: 3040-3045 Yang Y, Zhu X, Chen Y, Wang X, Chen R (2007) p38 and JNK MAPK, but not ERK1/2 MAPK, play important role in colchicine-induced cortical neurons apoptosis. Eur J Pharmacol 576: 26-33 Yu J, Zhang L (2005) The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331: 851-858 Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B (2001) PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells. Mol Cell 7: 673-682 < | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40646 | - |
dc.description.abstract | 許多抗癌藥物是由天然藥物所萃取或是再經過化學結構的修飾而來的,近年來公佈將近有一半的小分子全新化學物質新藥 (NCE),是經由天然物和其衍生物所衍生而來的,所以運用天然藥物作為新藥開發,在全球是非常具有潛力與發展力的。本篇論文中,我們發現石斛的萃取活性成分 denbinobin 與 moscatilin 可以對人類結腸直腸癌細胞株 HCT-116 在 in vitro 有引起細胞凋亡的作用,在 in vivo 有抑制腫瘤生長的效果。另外,南投秋海棠的萃取活性成分 cucurbitacin B 對人類結腸直腸癌細胞株 HT-29 則可誘發細胞凋亡作用。本篇論文探討這三個藥物是否具有開發為抗結腸直腸癌臨床用藥的潛力。
論文的第一部分為 denbinobin,是從大爪石斛 (Ephemerantha lonchophylla) 的莖所萃取出來的純化物,我們發現此一成分可以引起人類結腸直腸癌細胞株 HCT-116 細胞凋亡。研究結果發現 denbinobin 所造成的細胞凋亡機轉不是經由活化 caspase 途徑而來,denbinobin 主要是引起粒線體釋放出 apoptosis-inducing factor (AIF),AIF 會再進入細胞核引起細胞凋亡作用。另外,我們也發現 denbinobin 會引起 DNA damage,活化 p53 與其下游調控的蛋白。在活體動物實驗中,denbinobin 也能有效地抑制 HCT-116 腫瘤的生長,且對小鼠的毒性低。綜合以上實驗發現,denbinobin能經由粒線體釋放 AIF 以及引起 DNA damage,造成人類結腸直腸癌細胞株HCT-116 的細胞凋亡,加上動物實驗也證實能有效抑制 HCT-116 腫瘤細胞生長,所以我們認為 denbinobin 可以開發為新的抗癌藥物。 論文的第二部分為 moscatilin,是由環草石斛 (Dendrobrium loddigesii) 的莖所萃取出的純化物,我們發現此一成分可以引起人類結腸直腸癌細胞 HCT-116 細胞凋亡。Moscatilin 使細胞週期停止在 G2/M,並伴隨著 subG1 期的細胞(凋亡的細胞)數量增加。我們也發現 moscatilin 可以抑制微管蛋白的聚合作用,所以推測 moscatilin 會與微管蛋白結合。Moscatilin 也可以活化 JNK 及其下游的蛋白 c-Jun,進而活化 caspase 途徑而引起 HCT-116 細胞凋亡。另外,我們也發現 moscatilin 會引起 DNA damage,活化下游的 p53 蛋白與 p21WAF1/CIP1 蛋白。在活體動物實驗中,moscatilin 也證實呈現無毒性且能有效抑制 HCT-116 腫瘤細胞的生長。綜合以上實驗結果,我們認為 moscatilin 經由抑制微管蛋白聚合以及產生 DNA damage,經由活化 JNK 而啟動內生性途徑─ caspase-9 和 caspase-3,造成人類結腸直腸癌細胞株 HCT-116 的細胞凋亡作用。由於在動物實驗也有效的抑制 HCT-116 腫瘤生長,所以我們認為 moscatilin 可以開發為新的抗癌藥物。 論文的第三部分為 cucurbitacin B,從南投秋海棠 (Begonia nantoensis)所萃取出的三萜成分,可以在低濃度引起人類結腸直腸癌細胞 HT-29 細胞凋亡。Cucurbitacin B 會造成粒線體膜電位降低,並引起 Bcl-xL 蛋白磷酸化,Mcl-1 蛋白表現減少。Cucurbitacin B 也會造成 caspase-8、caspase-9、caspase-3 和 caspase-6 的活化,並造成下游受質 PARP 的分解,這表示 cucurbitacin B 可以引起內在途徑與外在途徑的 caspases 活化,進而造成細胞凋亡。Cucurbitacin B 會引起 HT-29 細胞週期停止在 G1 期;並增加 p21WAF1/CIP1 及 p27KIP1 的蛋白表現,抑制 CDK2、CDK4 及 cyclin E 的蛋白表現。Cucurbitacin B 也會造成 ERK、p38、JNK 及 Akt 的活化和抑制 STAT3 的磷酸化。總而言之,cucurbitacin B 會引起人類結腸直腸癌細胞 HT-29 細胞週期停止在 G1 期並且引起細胞凋亡。 | zh_TW |
dc.description.abstract | Natural products and their bio-active chemical derivatives have historically been invaluable as a source of novel cancer therapeutic agents. In recent decades, almost half of small-molecule New Chemical Entities (NCEs) were originally from natural products and their derivatives. To use natural products as a rich source of new drug development is a potential trend in the worldwide. In this thesis, we found denbinobin and moscatilin, isolated form traditional Chinese medicine - Herba dendrobii, were effective against the human colorectal cancer cells in vitro and in vivo. Cucurbitacin B, isolated from Begonia nantoensis, can induce apoptosis in human colorectal HT-29 cells. In this thesis, we study if these natural components can be new drugs against human colorectal cancer.
Denbinobin, a phenanthraquinone derivative isolated from the stems of Ephemerantha lonchophylla, induces apoptosis in human colon cancer HCT-116 cells. Interestingly, denbinobin induces apoptosis via caspase-independent pathway in HCT-116 cells. Denbinobin triggered the translocation of apoptosis-inducing factor (AIF) from the mitochondria into the nucleus. Denbinobin treatment also caused DNA damage, activation of the p53 tumor suppressor gene, and upregulation of numerous downstream effectors. A HCT-116 xenograft model demonstrated the in vivo efficacy and low toxicity of denbinobin. Taken together, our findings suggest that denbinobin induces apoptosis of human colorectal cancer HCT-116 cells via DNA damage and an AIF-mediated pathway. These results indicate that denbinobin has potential as a novel anti-cancer agent. Moscatilin, purified from the stem of the orchid (Dendrobrium loddigesii), induces apoptosis of human colorectal cancer HCT-116 cells. Moscatilin induced arrest of the cell-cycle at G2/M, with an associated decrease in cells at the G1 and an increase of cells at subG1. In addition, Moscatilin inhibited tubulin polymerization, suggesting that that it might bind to tubulins. Moscatilin also induced the phosphorylation of JNK1/2 and c-Jun, and this may contribute to caspase-dependent apoptosis signaling. Moreover, moscatilin induces DNA damage, activation of p53, and activation of the downstream effector p21WAF1/CIP1. A HCT-116 xenograft model demonstrated the in vivo efficacy and low toxicity of moscatilin. In summary, our results suggest that moscatilin induces apoptosis of colorectal HCT-116 cells via tubulin depolymerization and DNA damage stress and that this leads to the activation of JNK and mitochondria-involved intrinsic apoptosis pathway. These results indicate that moscatilin has potential as a novel anti-cancer agent. Cucurbitacin B, a triterpenoid isolated from Begonia nantoensis, induces apoptosis of human colorectal cancer HT-29 cells at low concentration. Cucurbitacin B reduced mitochondrial membrane potential, induced Bcl-xL phosphorylation, and reduced expression of Mcl-1. Cucurbitacin B-induced apoptosis of HT-29 cells was dependent on activation of the extrinsic and intrinsic apoptosis pathways, as indicated by its activation and processing of procaspase-8, -9, -3, -6 and PARP. Cucurbitacin B blocked HT-29 cells at the G1 phase, elevated the levels of p21WAF1/CIP1 and p27KIP1, and suppressed expression of CDK2, CDK4, and cyclin E. Cucurbitacin B significantly activated MAPKs (ERK, p38, JNK) and Akt, but inhibited STAT3 phosphorylation. Taken together, the results of our studies of HT-29 cells provide insight to the cucurbitacin B-induced arrest of cells at the G1 phase and the apoptosis of these cells. | en |
dc.description.provenance | Made available in DSpace on 2021-06-14T16:54:28Z (GMT). No. of bitstreams: 1 ntu-97-D91443007-1.pdf: 4973282 bytes, checksum: 821f5ece5913631750c7cc2b4c2d10ed (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 口試委員會審定書
誌謝………………………………………………………………………...i 縮寫表………………………………………………………………..iii 中文摘要………………………………………………………………...1 英文摘要………………………………………………………………...3 第一章…………………………………………………………………...7 第一節 研究動機與目的……………………………………………….7 第二節 文獻回顧……………………………………………………….9 第二章 實驗材料與方法……………………………………………...37 第一節 實驗材料………………………………………………...37 第二節 實驗方法………………………………………………...39 第三章 Denbinobin 引起 apoptosis-inducing factor 釋放和 DNA damage 造成 人類結腸直腸癌 HCT-116 細胞凋亡…………..………….49 中文摘要……………………………………………………………….50 英文摘要……………………………………………………………….51 第一節 緒論…………………………………………………………...52 第二節 結果…………………………………………………………...53 第三節 討論…………………………………………………………...57 第四章Moscatilin 引起人類結腸直腸癌細胞凋亡:使微管蛋白去聚合化作用和 引起 DNA damage 而引起 JNK 活化造成細胞凋亡之機轉探討…..……69 中文摘要……………………………………………………………….70 英文摘要……………………………………………………………….71 第一節 緒論…………………………………………………………...72 第二節 結果…………………………………………………………...73 第三節 討論…………………………………………………………...77 第五章 Cucurbitacin B 經由活化 caspase 路徑和引起細胞週期停止造成人類 結腸直腸癌HT-29細胞凋亡……………………………………………91 中文摘要……………………………………………………………….92 英文摘要……………………………………………………………….93 第一節 緒論…………………………………………………………...94 第二節 結果…………………………………………………………...95 第三節 討論…………………………………………………………...98 第六章 總結與展望………………………………………………….109 著作…………………………………………………….……………..112 參考文獻……………………………………………………………...117 | |
dc.language.iso | zh-TW | |
dc.title | Denbinobin, Moscatilin 及 Cucurbitacin B 在人類結腸直腸癌
引起細胞凋亡作用機轉之探討 | zh_TW |
dc.title | The Apoptotic Mechanisms of Denbinobin, Moscatilin and Cucurbitacin B in Human Colorectal Cancer Cell Lines | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 黃德富教授,蘇銘嘉教授,顏茂雄教授,楊春茂教授 | |
dc.subject.keyword | 結腸直腸癌,細胞凋亡,抗癌, | zh_TW |
dc.subject.keyword | colorectal cancer,apoptosis,moscatilin,denbinobin,cucurbitacin B, | en |
dc.relation.page | 133 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-07-30 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 4.86 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。